Literature DB >> 22366379

Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study.

Lauri Virta1, Anssi Auvinen, Hans Helenius, Pentti Huovinen, Kaija-Leena Kolho.   

Abstract

To determine whether childhood exposure to antibiotics is associated with the risk of developing inflammatory bowel disease (IBD), the authors conducted a national, register-based study comprising all children born in 1994-2008 in Finland and diagnosed with IBD by October 2010. The authors identified 595 children with IBD (233 with Crohn's disease and 362 with ulcerative colitis) and 2,380 controls matched for age, gender, and place of residence. The risk of pediatric Crohn's disease increased with the number of antibiotic purchases from birth to the index date and persisted when the 6 months preceding the case's diagnosis were excluded (for 7-10 purchases vs. none, odds ratio = 3.48, 95% confidence interval: 1.57, 7.34; conditional logistic regression). The association between Crohn's disease and antibiotic use was stronger in boys than in girls (P = 0.01). Cephalosporins showed the strongest association with Crohn's disease (for 3 purchases vs. nonuse, odds ratio = 2.82, 95% confidence interval: 1.65, 4.81). Antibiotic exposure was not associated with the development of pediatric ulcerative colitis. Repeated use of antibiotics may reflect shared susceptibility to childhood infections and pediatric Crohn's disease or alternatively may trigger disease development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366379     DOI: 10.1093/aje/kwr400

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  52 in total

1.  Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.

Authors:  David L Suskind; Mitchell J Brittnacher; Ghassan Wahbeh; Michele L Shaffer; Hillary S Hayden; Xuan Qin; Namita Singh; Christopher J Damman; Kyle R Hager; Heather Nielson; Samuel I Miller
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

Review 2.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

Review 3.  Probiotics in the next-generation sequencing era.

Authors:  Jotham Suez; Niv Zmora; Eran Elinav
Journal:  Gut Microbes       Date:  2019-04-05

Review 4.  Environmental triggers for IBD.

Authors:  Aoibhlinn O'Toole; Joshua Korzenik
Journal:  Curr Gastroenterol Rep       Date:  2014

5.  May bacterial or pancreatic proteases play a critical role in inflammatory bowel disease?

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

6.  Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis.

Authors:  Eileen S Alexander; Lisa J Martin; Margaret H Collins; Leah C Kottyan; Heidi Sucharew; Hua He; Vincent A Mukkada; Paul A Succop; J Pablo Abonia; Heather Foote; Michael D Eby; Tommie M Grotjan; Alexandria J Greenler; Evan S Dellon; Jeffrey G Demain; Glenn T Furuta; Larry E Gurian; John B Harley; Russell J Hopp; Amir Kagalwalla; Ajay Kaul; Kari C Nadeau; Richard J Noel; Philip E Putnam; Karl F von Tiehl; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2014-09-22       Impact factor: 10.793

7.  Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.

Authors:  Adam M Berg; Aamir N Dam; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-12

8.  Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis.

Authors:  Naomi L Ward; Caleb D Phillips; Deanna D Nguyen; Nanda Kumar N Shanmugam; Yan Song; Richard Hodin; Hai Ning Shi; Bobby J Cherayil; Allan M Goldstein
Journal:  Inflamm Bowel Dis       Date:  2016-10       Impact factor: 5.325

9.  Peripartum Antibiotics Promote Gut Dysbiosis, Loss of Immune Tolerance, and Inflammatory Bowel Disease in Genetically Prone Offspring.

Authors:  Jun Miyoshi; Alexandria M Bobe; Sawako Miyoshi; Yong Huang; Nathaniel Hubert; Tom O Delmont; A Murat Eren; Vanessa Leone; Eugene B Chang
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

10.  Editorial: Increasing Incidence of Pediatric Inflammatory Bowel Disease in France: Implications for Etiology, Diagnosis, Prognosis, and Treatment.

Authors:  Edward L Barnes; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2018-02       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.